Capital Investment Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78K | Hold |
22
| – | – | ﹤0.01% | 1016 |
|
|
2025
Q1 | $2.81K | Sell |
22
-4,331
| -99% | -$554K | ﹤0.01% | 949 |
|
|
2024
Q4 | $576K | Buy |
4,353
+13
| +0.3% | +$1.72K | 0.06% | 262 |
|
|
2024
Q3 | $632K | Buy |
4,340
+20
| +0.5% | +$2.91K | 0.06% | 253 |
|
|
2024
Q2 | $593K | Sell |
4,320
-124
| -3% | -$17K | 0.06% | 261 |
|
|
2024
Q1 | $610K | Buy |
4,444
+4,312
| +3,267% | +$592K | 0.07% | 268 |
|
|
2023
Q4 | $17.9K | Hold |
132
| – | – | ﹤0.01% | 757 |
|
|
2023
Q3 | $16.1K | Sell |
132
-400
| -75% | -$48.7K | ﹤0.01% | 720 |
|
|
2023
Q2 | $67.5K | Sell |
532
-3,167
| -86% | -$402K | 0.01% | 576 |
|
|
2023
Q1 | $478K | Buy |
3,699
+1
| +0% | +$129 | 0.06% | 266 |
|
|
2022
Q4 | $486K | Buy |
3,698
+70
| +2% | +$9.19K | 0.06% | 275 |
|
|
2022
Q3 | $424K | Buy |
3,628
+3,176
| +703% | +$371K | 0.06% | 278 |
|
|
2022
Q2 | $53K | Buy |
452
+430
| +1,955% | +$50.4K | 0.01% | 588 |
|
|
2022
Q1 | $3K | Sell |
22
-75
| -77% | -$10.2K | ﹤0.01% | 802 |
|
|
2021
Q4 | $15K | Buy |
97
+22
| +29% | +$3.4K | ﹤0.01% | 698 |
|
|
2021
Q3 | $12K | Hold |
75
| – | – | ﹤0.01% | 669 |
|
|
2021
Q2 | $12K | Sell |
75
-40
| -35% | -$6.4K | ﹤0.01% | 694 |
|
|
2021
Q1 | $17K | Buy |
115
+75
| +188% | +$11.1K | ﹤0.01% | 622 |
|
|
2020
Q4 | $6K | Hold |
40
| – | – | ﹤0.01% | 649 |
|
|
2020
Q3 | $5K | Hold |
40
| – | – | ﹤0.01% | 575 |
|
|
2020
Q2 | $5K | Buy |
+40
| New | +$5K | ﹤0.01% | 515 |
|
|
2019
Q3 | – | Sell |
-30
| Closed | -$3K | – | 1413 |
|
|
2019
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 1225 |
|
|
2019
Q1 | $3K | Hold |
30
| – | – | ﹤0.01% | 1052 |
|
|
2018
Q4 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 1002 |
|